U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625189) titled 'EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry' on April 02.

Brief Summary: This is a single-center, investigator-initiated, prospective observational registry that will collect longitudinal clinical data on adult patients (>=18 years) undergoing endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) or microwave ablation (MWA) for pancreatic and other gastrointestinal/hepatobiliary lesions as part of routine clinical care. The registry will not alter standard-of-care management. Data will be abstracted from the medical record and routine clinical systems. Primary outcomes inclu...